IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures
Recent advances in next-generation sequencing (NGS) technologies have triggered the rapid accumulation of publicly available multi-omics datasets. The application of integrated omics to explore robust signatures for clinical translation is increasingly emphasized, and this is attributed to the clini...
Main Authors: | Dongqiang Zeng, Zilan Ye, Rongfang Shen, Guangchuang Yu, Jiani Wu, Yi Xiong, Rui Zhou, Wenjun Qiu, Na Huang, Li Sun, Xuejun Li, Jianping Bin, Yulin Liao, Min Shi, Wangjun Liao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.687975/full |
Similar Items
-
Multi-dimensional omics characterization in glioblastoma identifies the purity-associated pattern and prognostic gene signatures
by: Yi Xiong, et al.
Published: (2020-01-01) -
Editorial: Multi-omics approaches for decoding heterogeneity in cancer immunotherapy
by: Aimin Jiang, et al.
Published: (2023-11-01) -
Single-cell analysis of a tumor-derived exosome signature correlates with prognosis and immunotherapy response
by: Jiani Wu, et al.
Published: (2021-09-01) -
Multi-Omics Profiling of the Tumor Microenvironment: Paving the Way to Precision Immuno-Oncology
by: Francesca Finotello, et al.
Published: (2018-10-01) -
Identifying subpathway signatures for individualized anticancer drug response by integrating multi-omics data
by: Yanjun Xu, et al.
Published: (2019-08-01)